N. Paoni

F. Peale, Renhui Yang, A. Ogasawara, 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Effects of exercise training on cardiac function, gene expression, and apoptosis in rats.

Wei Li, Renhui Yang, A. Ogasawara, 2000, American journal of physiology. Heart and circulatory physiology.

Effects of cardiotrophin-1 on haemodynamics and cardiac function in conscious rats.

W. Wood, H. Jin, R. Yang, 1998, Cytokine.

Beneficial Effects of Growth Hormone and Insulin‐Like Growth Factor‐1 in Experimental Heart Failure in Rats Treated with Chronic ACE Inhibition

R. Clark, Renhui Yang, Hongkui Jin, 1995, Journal of cardiovascular pharmacology.

Time course of skeletal muscle repair and gene expression following acute hind limb ischemia in mice.

F. Peale, P. Williams, M. Gerritsen, 2002, Physiological genomics.

Site-directed mutagenesis of tissue-type plasminogen activator

B. Keyt, N. Paoni, W. Bennett, 1996 .

In vivo effects of cardiotrophin-1.

W. Wood, Renhui Yang, H. Jin, 1996, Cytokine.

Inhibitory effects of interferon-γ on myocardial hypertrophy

Renhui Yang, A. Ogasawara, Hongkui Jin, 2005 .

A Variant of t-PA (T103N, KHRR 296-299 AAAA) that, by Bolus, Has Increased Potency and Decreased Systemic Activation of Plasminogen

B. Keyt, F. Wurm, N. Paoni, 1993, Thrombosis and Haemostasis.

Making tissue-type plasminogen activator more fibrin specific.

B. Keyt, A. Chow, M. Zoller, 1993, Protein engineering.

Isolation of a low molecular weight form of plasminogen.

F. Castellino, N. Paoni, 1975, Biochemical and biophysical research communications.

High resolution analysis of functional determinants on human tissue-type plasminogen activator.

D. Botstein, B. Keyt, L. Presta, 1991, The Journal of biological chemistry.

Cardiotrophin-1

W. Wood, D. Pennica, T. Taga, 1995, The Journal of Biological Chemistry.

Improved method for detection of glycosidases in bacterial colonies

N. Paoni, R. L. Arroyo, 1984, Applied and Environmental Microbiology.

Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.

F. Castellino, V. Ploplis, N. Paoni, 2003, Physiological genomics.

Isolation and characterization of native and lower molecular weight forms of sheep plasminogen.

B. Violand, F. Castellino, N. Paoni, 1977, The Journal of biological chemistry.

Permeabilization of cells for studies on the biochemistry of bacterial chemotaxis.

D. Koshland, N. Paoni, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Expression profiling techniques for cardiac molecular phenotyping.

N. Paoni, D. Lowe, 2001, Trends in cardiovascular medicine.

RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR: BIOCHEMISTRY, PHARMACOLOGY, AND PROCESS DEVELOPMENT§

N. Paoni, S. Builder, J. Ogez, 1991 .

A faster-acting andmorepotent formoftissue plasminogen activator

B. Keyt, N. Paoni, C. Refino, 1994 .

Early Treatment with Hepatocyte Growth Factor Improves Cardiac Function in Experimental Heart Failure Induced by Myocardial Infarction

D. Eberhard, R. Schwall, Renhui Yang, 2003, Journal of Pharmacology and Experimental Therapeutics.

21 – Chemical Sensing by Bacteria

D. Koshland, N. Paoni, Ann M. Maderis, 1981 .

The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.

M. Suckow, F. Castellino, R. Navari, 2004, Cancer letters.

A comparison of the urokinase and streptokinase activation properties of the native and lower molecular weight forms of sheep plasminogen.

F. Castellino, N. Paoni, 1979, The Journal of biological chemistry.

Therapy with ribozyme to the proliferating cell nuclear antigen-ribozyme and 5-fluorouracil of experimental choroidal neovascularization in rats.

W. Freeman, S. Azen, I. Kozák, 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.